Ezetimibe is a drug that selectively inhibits cholesterol absorption and further reduces LDL-C when used in addition to statins. The ENHANCE trial is a randomized study aimed at studying the ...
Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...
Ezetimibe reduces LDL cholesterol levels, and niacin raises HDL cholesterol levels; however, no previous studies have described the use of these two drugs in combination. Jelesoff and colleagues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results